Advanced glycation endproducts regulate smooth muscle cells calcification in cultured HSMCs

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 10, 2015, Pages 12260-12267

  He, Hu Qiang ^a   Liu, Yong ^a   Zeng, Hong ^a   Sun, Xiao Lei ^a   Zhang, Lei ^a   Zhang, Xue Lin ^a   Liao, Wen Jun ^a   Zhou, Xiang Yu ^a   He, Yan Zheng ^a  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

AGEs; Calcification; HSMCs; OPG; RAGE; catenin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; BETA CATENIN; BOVINE SERUM ALBUMIN; CADHERIN; CALCIUM;

CALCINOSIS; CELL CULTURE; HUMAN; METABOLISM; PATHOLOGY; RANDOMIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

BETA CATENIN; CADHERINS; CALCINOSIS; CALCIUM; CELLS, CULTURED; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RANDOM ALLOCATION; SERUM ALBUMIN, BOVINE; SIGNAL TRANSDUCTION;

EID: 85013218738     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Zhao B, Li X, Dai X, Gong N. Adenovirus-mediated anti-sense extracellular signal-regulated kinase 2 gene therapy inhibits activation of vascular smooth muscle cells and angiogenesis, and ameliorates transplant arteriosclerosis. Transplant Proc 2013; 45: 639-42.
2. Basta G. Receptor for advanced glycation end products and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008; 196: 9-21.
3. Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004; 53: 1813-1823.
4. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res 2009; 46: 572-80.
5. Li G, Xu J, Li Z. Receptor for advanced glycation end products inhibits proliferation in osteoblast through suppression of Wnt, PI3K and ERK signaling. Biochem Biophys Res Commun 2012; 423: 684-9.
6. Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005; 8: 727-38.
7. Zieman SJ, Melenovsky V, Clattenburg L, Corretti MC, Capriotti A, Gerstenblith G, Kass DA. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens 2007; 25: 577-83.
8. Ramasamy R, Yan SF, Schmidt AM. Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts. Mol Nutr Food Res 2007; 51: 1111-5.
9. Wautier MP, Tessier FJ, Wautier JL. Advanced glycation end products: A risk factor for human health. Ann Pharm Fr 2014; 72: 400-408.
10. Lin L, Park S, Lakatta EG. RAGE signaling in inflammation and arterial aging. Front Biosci (Landmark Ed) 2009; 14: 1403-13.
11. Van Puyvelde K, Mets T, Njemini R, Beyer I, Bautmans I. Effect of advanced glycation end product intake on inflammation and aging: a systematic review. Nutr Rev 2014; 72: 638-50.
12. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93: 1143-52.
13. Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis 2014; 238: 370-379.
14. Crauwels HM, Herman AG, Bult H. Local application of advanced glycation end products and intimal hyperplasia in the rabbit collared carotid artery. Cardiovasc Res 2000; 47: 173-82.
15. Wang X, Jin A, An M, Ding Y, Tuo Y, Qiu Y. Etomidate deteriorates the toxicity of advanced glycation end products to human endothelial Eahy926 cells. J Toxicol Sci 2014; 39: 887-96.
16. Yamamoto T. The role of AGEs for the pathogenesis of osteopenia in diabetes mellitus. Clin Calcium 2006; 16: 1322-26.